Do not freeze
Wegovy, another brand name formulation of semaglutide, is FDA-approved for weight management in obese individuals with a body mass index (BMI) over 30 or overweight individuals with a BMI over 27, and at least one weight-related health condition, including high cholesterol, Type 2 diabetes, and high blood pressure
Its essential to understand that while semaglutide GLP-1 can be a valuable tool in reducing belly fat, consistent lifestyle modifications, and ongoing support are key to long-term success in managing weight and improving overall health
Pregnant and breastfeeding women : Pregnant women should use the drug after weighing the pros and cons, and breastfeeding women should stop breastfeeding when using the drug
During this phase, youll begin with a low dose that is gradually increased, to allow your body to adjust to the medication and minimize side effects